Related Experiment Video
Updated: May 16, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Clinical Gaze in Risk-Factor Haze: Swedish GPs' Perceptions of Prescribing Cardiovascular Preventive Drugs
Josabeth Hultberg1, Carl Edvard Rudebeck
1Åby Health Care Centre, County Council of Östergötland, Department of Medical and Health Sciences, General Practice, Faculty of Health Sciences, Linköping University, 581 85 Linköping, Sweden.
General practitioners involve patients in cardiovascular drug decisions, especially when risks are low. Patient involvement decreases with higher perceived cardiovascular risk, impacting treatment choices.
Area of Science:
- Cardiology
- General Practice
- Health Communication
Background:
- Cardiovascular preventive drug prescribing is a key aspect of primary care.
- Understanding general practitioners' (GPs) decision-making processes is crucial for optimizing patient care.
- Previous research has explored prescribing patterns, but less is known about the nuances of patient involvement in these decisions.
Purpose of the Study:
- To explore general practitioners' (GPs) descriptions of their thought processes and actions when prescribing cardiovascular preventive drugs.
- To understand how GPs negotiate patient involvement in treatment decisions based on perceived cardiovascular risk.
Main Methods:
- Qualitative content analysis of transcribed group interviews.
- 14 GPs from two primary health care centers in southeast Sweden participated.
- The analysis focused on GPs' descriptions of their prescribing behaviors and patient interactions.
Main Results:
- GPs described prescribing as a negotiation between "the patient as calculated" and "the inclination to prescribe" when interacting with "the patient in front of me."
- A directive consultation style was reported in high cardiovascular risk situations.
- In low-risk or uncertain benefit situations, GPs favored informed patient choice.
Conclusions:
- GPs tend to involve patients more in treatment decisions when cardiovascular risk is low or uncertain.
- Patient involvement decreases when GPs perceive cardiovascular risk as high.
- Findings highlight the need for enhanced communication skills training for clinicians to ensure consistent patient engagement in cardiovascular preventive care.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Atherosclerosis III: Management
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Rheumatic Heart Disease III: Medical Management